![Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile](https://i1.rgstatic.net/ii/profile.image/1016719615217671-1619416254600_Q512/Palma-Rocchi.jpg)
Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile
Palma Rocchi - CV - Targeting Hsp27 Stress Induced Signaling Pathways in Castration-Resitant Prostate Cancer
![PSMA-Targeted Radionuclide Therapy and salivary gland toxicity: why does it matter? | Journal of Nuclear Medicine PSMA-Targeted Radionuclide Therapy and salivary gland toxicity: why does it matter? | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/early/2018/02/08/jnumed.118.207993.extract.jpg)
PSMA-Targeted Radionuclide Therapy and salivary gland toxicity: why does it matter? | Journal of Nuclear Medicine
![International Journal of Cancer and Clinical Research Editorial Board | Clinmed International Library International Journal of Cancer and Clinical Research Editorial Board | Clinmed International Library](https://clinmedjournals.org/editing/photos/International-Journal-of-Cancer-and-Clinical-Research/16626733.jpg)
International Journal of Cancer and Clinical Research Editorial Board | Clinmed International Library
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
![DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer: Molecular Therapy DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer: Molecular Therapy](https://www.cell.com/cms/asset/7e58e6ee-8782-45ab-829c-a6cbdd6ca28f/fx1.jpg)
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer: Molecular Therapy
![Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile](https://www.researchgate.net/profile/Palma-Rocchi/publication/335533720/figure/fig1/AS:1019260134494211@1620021961967/A-Phenazine-14-formulation-with-DOU-PEG2000-N-5-2-3-dioleoyluridine-N-N-N_Q320.jpg)
Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile
![Pharmaceutics | Free Full-Text | Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer Pharmaceutics | Free Full-Text | Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00623/article_deploy/html/images/pharmaceutics-13-00623-g005-550.jpg)
Pharmaceutics | Free Full-Text | Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer
![Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity | Oncogene Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41388-021-02039-2/MediaObjects/41388_2021_2039_Fig7_HTML.png)